Regeneron’s cover photo
Regeneron

Regeneron

Biotechnology

Tarrytown, New York 641,523 followers

About us

At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.

Website
http://www.regeneron.com
Industry
Biotechnology
Company size
10,001+ employees
Headquarters
Tarrytown, New York
Type
Public Company

Locations

Employees at Regeneron

Updates

  • As we enter our next decade as the title sponsor of Regeneron Science Talent Search (STS), we’re reflecting on the incredible journeys of STS winners from the past ten years, and the impact on the future of scientific advancement. 🎓 These remarkable young scientists continue to shape the world in ways that inspire us every day. STS, a program of Society for Science, is the nation’s oldest and most prestigious science and technology competition for high school students. Here’s to the leaders, explorers, and problem solvers who started their journey at STS and brilliant scientific leaders to come.    #RegeneronSTEMFueled 

  • Throwback to 2013. We aimed to sequence 100,000 exomes in five years through the work of Regeneron Genetics Center, then one of the largest efforts in the world.     Over a decade later, that first milestone looks more like a starting line. We’ve since surpassed 3 million exomes sequenced.    The technology has advanced. The collaborations have expanded. The datasets have grown. What remains constant is why we do it: ground discovery in human genetics so we can advance science and deliver better medicines to patients. 

  • 🔬 What are you looking at?      Hint: This image wasn’t captured by a camera. It was created using AI that turns scientific data into vivid visuals—helping Regeneron scientists see biology in new ways.

  • View organization page for Regeneron

    641,523 followers

    How did we overcome bottlenecks in genetic engineering? By identifying what was holding us back and creating breakthrough solutions.    Following the principles of our co-founder, President, and Chief Scientific Officer, George D. Yancopoulos, our scientists developed VelociGene®, a groundbreaking technology that enables large-scale edits to mouse DNA, creating a fully human immune system in mice.    This innovation fundamentally changed how we develop therapeutic human antibodies, accelerating the path from discovery to potential treatments for patients in need. Watch the full video: https://bit.ly/4cNGlzq

  • 🚀 Last week, we traveled to Washington, D.C. to celebrate the 2026 Regeneron Science Talent Search (STS) finalists.   These remarkable students showcased their extraordinary ideas, curiosity, creativity, and determination, reminding us why this program matters so deeply. We were also proud to announce our continued partnership with Society for Science, renewing our title sponsorship of #RegeneronSTS for another decade. This commitment reflects our belief in the power of young minds to transform the future.  As a program of Society for Science, STS shines a spotlight on young scientists whose ideas are pushing the future of science forward.  Take a look at the students’ standout moments from Finalists’ Week. #RegeneronSTEMFueled

  • From Tarrytown to Dublin and beyond, colleagues came together for our first #TEDxRegeneron hosted by our Culture and Development team. Twelve speakers from across the company shared personal stories and bold perspectives, and an interactive expo sparked new conversations and connections. Thank you to the speakers, expo contributors, and the many colleagues who brough the day to life. Investing in our people's voices - and learning from one another - keeps our culture moving forward. We're already looking ahead to #TEDxRegeneron 2027, with even more ideas, more voice, and deeper connections across our global community.

    • TEDxRegeneron 2026 Speakers
  • Our genes influence more than who we are. They have the power to control disease development, treatment response, and innovation in medicine. It’s #GeneticsAwarenessWeek and we’re sharing how Regeneron Genetics Center builds large-scale, representative genomic databases and connects DNA insights with real-world impact. We help unlock discoveries that could transform how we understand and treat disease. 🧬 👉 Watch one of the first steps in our Regeneron Scientific Journey: https://bit.ly/3OIWmN4 #HumanGenetics

Affiliated pages

Similar pages

Browse jobs

Funding

Regeneron 3 total rounds

Last Round

Post IPO equity

US$ 2.0M

See more info on crunchbase